Navigation Links
Merck Serono et l'Institut Feinstein vont s'associer pour développer un programme pré-clinique portant sur les maladies inflammatoires
Date:1/29/2013

met à la disposition des patients, dans 150 pays, des médicaments majeurs dans les domaines de l'oncologie, de la sclérose en plaques, de l'infertilité, des troubles endocriniens et métaboliques, ainsi que dans le domaine des maladies cardio-vasculaires. Aux États-Unis et au Canada, EMD Serono opère en tant que filiale juridiquement indépendante de Merck Serono.

Merck Serono découvre, développe, produit et commercialise des médicaments de prescription, obtenus par synthèse chimique ou issus de la biotechnologie, dans des indications relevant de spécialistes médicaux. Nous avons pris l'engagement sur le long terme de développer de nouveaux traitements dans nos domaines thérapeutiques cibles que sont l'oncologie, la neurologie et l'immunologie.

À propos de Merck

Fort d'une histoire qui a commencé en 1668 et d'un avenir construit grâce à plus de 40 000 salariés répartis dans 67 pays, Merck est un groupe pharmaceutique et chimique mondial, dont les ventes se sont élevées à 10,3 milliards d'euros en 2011. L'une des clés de sa réussite tient au sens de l'innovation de ses employés. Les activités de Merck sont chapeautées par la société Merck KGaA, dont le capital est détenu à hauteur d'environ 70% par la famille Merck et à hauteur d'environ 30% par des actionnaires extérieurs. L'ancienne filiale américaine Merck & Co. est totalement autonome depuis 1917, et n'a depuis plus aucun lien avec le groupe Merck.

Pour plus d'informations, veuillez consulter les sites http://www.merckserono.com ou http://www.merckgroup.com


'/>"/>
SOURCE Merck Serono S A
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Symphogen Grants Exclusive Worldwide License of Phase II Oncology Drug Candidate Sym004 to Merck KGaA
2. Merck Company Foundation Announces HIV Care Collaborative with Atlanta, Houston and Philadelphia Health Departments
3. Ambrx Collaborates with Merck to Design and Develop Biologic Drug Conjugates
4. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
5. Trinity College Dublins Neuroscience and Bioengineering Programmes Receive Postgraduate Course of the Year Awards
6. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
7. Appeal Courts Direction on Claim Construction Is Strategically Important for Butamaxs Case Against Gevo Scheduled for April 2013
8. Man-made pores mimic important features of natural pores
9. Building Wireless Solution More Important than Ever with New Tablets
10. Carbon nanotubes can double growth of cell cultures important in industry
11. Spherix Announces Successful Completion of Important Toxicology Study of SPX-106
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... The report expects global cell isolation and expansion ... provides a carefully analyzed data about the vital drivers, ... , Full Copy of Report @ http://bit.ly/1yUxy0T ... cell expansion will keep witnessing growth at an impressive ... be driven by rapid technological advancements, government funding and ...
(Date:12/24/2014)... -- PharmaBoardroom,s new report, , Healthcare ... for free download , digs deep into this vibrant ... the sector today. One area where ... developing a homegrown pharmaceutical manufacturing base, even if the government,s ... way off. A cursory comparison with neighboring Morocco ...
(Date:12/22/2014)... & Brussels (PRWEB) December 22, 2014 ... (CfPIE), the global leader of technical training across the ... for Clinical Data Management (SCDM) to provide the ... certification programs —providing access to the more than ... extends SCDM members with 10% off when registering for ...
(Date:12/22/2014)... GenomeDx Biosciences today announced that a new ... genomic test for prostate cancer, was able to predict ... radical prostatectomy without adjuvant therapy. Although rapid metastasis in ... tumor genomics to identify these men who have a ... advance. The study has been published online by ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3
... In Total Revenue To $5.6 Million; 34% Increase in ... International Isotopes Inc. (OTC Bulletin Board: INIS) announces ... 2008. Total Revenue . Total ... 2007, which represents an increase of $911,885 or 19.4%. ...
... 27 Human Genome Sciences, Inc. (Nasdaq: ... at the 4th Annual Citi Biotech Day will be ... . (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ... team will present a corporate overview on Wednesday, April ...
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: ... develops and commercializes prescription drugs for the treatment ... the fourth quarter and year ended December 31, ... J. McEnany, Chief Executive Officer of Catalyst Pharmaceutical ...
Cached Biology Technology:International Isotopes Inc. Announces Year End Financial Results 2International Isotopes Inc. Announces Year End Financial Results 3International Isotopes Inc. Announces Year End Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 5Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 6
(Date:12/4/2014)... PALM BEACH GARDENS, Fla. , Dec. 3, ... identity management solutions, today announced that its DigitalPersona ... 4500 fingerprint readers have been deployed throughout ... Carolina , South Carolina ... network headquartered in Southern Pines, North ...
(Date:12/3/2014)... 2014 As part of our commitment to ... pleased to announce the release of a new reader ... the workforce data that they need. The ... by existing readers. Many such devices have serious shortcomings ... technology. Older models force users to navigate numerous complicated ...
(Date:11/21/2014)... 2014  Earlier this year Donald Spector , ... one of the most prolific inventors in the world, ... from Smartphones to third party agencies. Spector envisioned this ... of the earliest known patents in this area. Now ... military, child care, elder care and hospital applications. This ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Inception Technologies to Release New Biometric Reader 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4
... epic 354-million-mile trek through space, the Mars Curiosity Rover ... a scheduled August 6 landing on the Red Planet ... episode of the American Chemical Society,s (ACS,) award-winning ... scientific instrumentation and the role that chemistry plays in ...
... stress, a new research report appearing in the August 2012 ... suggests that what your mother ateor didn,t eatmay be part ... is higher than what is generally recommended during pregnancy may ... the result of epigenetic changes that ultimately lead to lower ...
... a smog-filled sky or a contaminated river, according to ... just for the prosperous. People living in China,s ... are more likely to begreen: re-using their plastic grocery ... in the international journal AMBIO , indicates that ...
Cached Biology News:Sick from stress? Blame your mom… and epigenetics 2Pollution can make citizens - both rich and poor - go green 2
... Mung Bean Nuclease catalyzes the degradation of ... 5-phosphoryl terminated products. While the nuclease prefers ... high concentrations the enzyme degrades double-stranded DNA ... has been used for transcript mapping studies ...
... The S.c. EasyComp Transformation Kit ... transformation-competent Saccharomyces cerevisiae cells. Advantages over ... spheroplast formation or LiCl methods include:- Cells ... than 30 minutes - Competent cell preparation ...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
...
Biology Products: